[Positive Pneumocystis jirovecii PCR in immunocompromised patients with a systemic disease: infection or

A Mekinian1, V Queyrel, I Durand-Joly

  • 1hôpital Claude-Huriez, CHRU de Lille, France. arsene150@yahoo.fr

La Revue De Medecine Interne
|January 5, 2010
PubMed
Abstract

Insights

A positive Pneumocystis jirovecii PCR test in patients with systemic diseases doesn't always confirm Pneumocystis pneumonia. However, severe immunosuppression warrants considering treatment even with a positive PCR.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Pneumocystis pneumonia (PCP) is a severe opportunistic infection.
  • PCP commonly affects HIV-seropositive individuals and those with systemic diseases.
  • The diagnostic utility of Pneumocystis jirovecii PCR in systemic disease patients is unclear.

Purpose of the Study:

  • To evaluate the diagnostic value of a positive Pneumocystis jirovecii PCR in respiratory samples.
  • To assess Pneumocystis pneumonia diagnosis in patients with systemic diseases.

Main Methods:

  • Retrospective study of 73 patients with systemic disease and respiratory symptoms.
  • Respiratory sampling and Pneumocystis jirovecii PCR testing over a 10-year period.
  • Comparison of patients diagnosed with PCP versus those colonized.

Main Results:

  • P. jirovecii PCR was positive in 20 patients; PCP was diagnosed in nine.
  • Microscopic examination was negative in six of the nine PCP patients.
  • PCP patients had lower CD4+ counts, more immunosuppressive treatment, and lacked prophylaxis compared to colonized patients.

Conclusions:

  • A positive P. jirovecii PCR does not definitively indicate Pneumocystis pneumonia.
  • Treatment for PCP should be considered in severely immunosuppressed patients without prophylaxis, despite a positive PCR.
  • Distinguishing infection from colonization is crucial for appropriate management.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...